aTyr Pharma Inc. (ATYR)
3.29
-0.67 (-16.81%)
At close: Mar 03, 2025, 3:59 PM
3.29
-0.15%
After-hours: Mar 03, 2025, 07:53 PM EST
aTyr Pharma Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 353K | 10.39M | n/a | 10.46M | 422K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 2.74M | 1.7M | 1.3M | 17.29M | 14.05M | 746K | 713K | 900K | n/a | n/a | n/a | 540K |
| Gross Profit | -2.39M | 8.69M | -1.3M | -6.84M | -13.63M | -746K | -713K | -900K | n/a | n/a | n/a | -540K |
| Operating Income | -54.92M | -46.4M | -34.02M | -15.91M | -22.98M | -32.82M | -47.15M | -59.34M | -47.62M | -23.55M | -19.54M | -12.6M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65K | n/a | n/a | n/a | n/a |
| Pretax Income | -50.4M | -45.34M | -33.78M | -16.23M | -23.76M | -34.52M | -48.21M | -57.9M | -47.97M | -24.35M | -20.01M | -12.86M |
| Net Income | -50.39M | -45.34M | -33.77M | -16.22M | -23.6M | -34.52M | -48.21M | -57.85M | -47.97M | -24.35M | -20.01M | -17.61M |
| Selling & General & Admin | 12.98M | 12.29M | 9.45M | 7.81M | 7.99M | 11.69M | 16.36M | 14.19M | 13.11M | 6.78M | 5.71M | 4.31M |
| Research & Development | 42.29M | 42.81M | 23.26M | 17.29M | 14.05M | 20.39M | 30.07M | 44.25M | 34.5M | 16.78M | 13.83M | 7.75M |
| Other Expenses | n/a | 1.06M | 238K | -319K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 55.27M | 55.09M | 32.71M | 25.1M | 22.03M | 32.07M | 46.43M | 58.44M | 47.62M | 23.55M | 19.54M | 12.06M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 832K | 444K | 272K |
| Selling & Marketing Expenses | n/a | -1.7M | -1.3M | -1.27M | -1.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 55.27M | 56.79M | 34.02M | 26.37M | 23.4M | 32.82M | 47.15M | 59.34M | 47.62M | 23.55M | 19.54M | 12.6M |
| Income Tax | n/a | -5K | -9K | -6K | -160K | 1.00 | n/a | -49K | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 53.61M | 28.42M | 19.08M | 9.16M | 3.36M | 2.14M | 1.84M | 1.69M | 1.13M | 58.59K | 50.36K | 394.19K |
| Shares Outstanding (Diluted) | 53.61M | 28.42M | 19.08M | 9.16M | 3.36M | 2.14M | 1.84M | 1.69M | 1.13M | 59.59K | 54.48K | 394.19K |
| EPS (Basic) | -0.94 | -1.6 | -1.77 | -1.77 | -7.03 | -16.13 | -26.16 | -34.2 | -42.42 | -422.73 | -429.9 | -44.67 |
| EPS (Diluted) | -0.94 | -1.6 | -1.77 | -1.77 | -7.03 | -16.13 | -26.16 | -34.2 | -42.42 | -415.63 | -397.39 | -44.67 |
| EBITDA | -52.18M | -44.71M | -32.47M | -14.64M | -21.61M | -32.07M | -46.43M | -57M | -45.35M | -22.73M | -18.83M | -12.05M |
| Depreciation & Amortization | 2.74M | 1.7M | 1.3M | 1.27M | 1.37M | 746K | 713K | 900K | 869K | 829K | 714K | 540K |